By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – BioServe said today that it will provide its genetic testing services for NGC Medical's nutrigenomics testing business.

Under the agreement, BioServe will provide Italy's NGC Medical with its CLIA-certified genomics services, including DNA extraction, QC DNA, and control DNA for the NutriGeneCode testing service.

Beltsville, Md.-based BioServe said that it expects to process around 10,000 NutriGeneCode tests in the next year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.